Nasdaq Stockholm Welcomes Pharmacolog to First North
Stockholm, May 28, 2018— Nasdaq (Nasdaq: NDAQ) announces that the trading in Pharmacolog i Uppsala AB’s shares (short name: PHLOG B) will commence today on Nasdaq First North in Stockholm. Pharmacolog i Uppsala AB (“Pharmacolog”) belongs to the healthcare sector and is the 31st company to be admitted to trading on Nasdaq’s Nordic markets* in 2018.
Pharmacolog is a Swedish healthcare company specialized in providing quality assurance solutions for safe administration of medical drugs. The company develops solutions and products that can prevent drug administration errors reaching the treated patient. The company’s lead product, DrugLog, focuses on the quality assurance in drug administration in the hospital pharmacy and the clinical ward. Pharmacolog was founded in 2007 and is headquartered in Uppsala, Sweden. For more information, please visit www.pharmacolog.com.
“Pharmacolog is embarking on an exciting journey towards long term growth with today’s Nasdaq First North listing,” said Mats Högberg, CEO of Pharmacolog. “Our strategy is clear and a successful new share issue will enable us to accelerate our operations and enter the US market. We sincerely welcome both old and new shareholders as we take this step, and we are determined to continue to work hard to improve patient care and to keep creating value for our shareholders.”
”We welcome Pharmacolog to Nasdaq First North,” said Adam Kostyál, SVP and Head of European Listings, Nasdaq. “Pharmacolog joins our growing healthcare sector, and we look forward to supporting them with the increased visibility that comes with a Nasdaq First North listing.”
Pharmacolog i Uppsala AB has appointed Mangold Fondkommission AB as the Certified Adviser.
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About Nasdaq First North
Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.